Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies
View ORCID ProfileKayoko Shioda, Max SY Lau, Alicia NM Kraay, Kristin N Nelson, View ORCID ProfileAaron J Siegler, View ORCID ProfilePatrick S Sullivan, Matthew H Collins, View ORCID ProfileJoshua S Weitz, Benjamin A Lopman
doi: https://doi.org/10.1101/2020.11.13.20231266
Kayoko Shioda
1Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA
Max SY Lau
2Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA
Alicia NM Kraay
3Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
Kristin N Nelson
3Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
Aaron J Siegler
3Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
Patrick S Sullivan
3Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
Matthew H Collins
4Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
Joshua S Weitz
5School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA; School of Physics, Georgia Institute of Technology, Atlanta, GA, USA
Benjamin A Lopman
3Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
Article usage
Posted November 16, 2020.
Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies
Kayoko Shioda, Max SY Lau, Alicia NM Kraay, Kristin N Nelson, Aaron J Siegler, Patrick S Sullivan, Matthew H Collins, Joshua S Weitz, Benjamin A Lopman
medRxiv 2020.11.13.20231266; doi: https://doi.org/10.1101/2020.11.13.20231266
Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies
Kayoko Shioda, Max SY Lau, Alicia NM Kraay, Kristin N Nelson, Aaron J Siegler, Patrick S Sullivan, Matthew H Collins, Joshua S Weitz, Benjamin A Lopman
medRxiv 2020.11.13.20231266; doi: https://doi.org/10.1101/2020.11.13.20231266
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2833)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12534)
- Forensic Medicine (10)
- Gastroenterology (800)
- Genetic and Genomic Medicine (4413)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2840)
- Health Policy (1045)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4168)
- Nursing (220)
- Nutrition (615)
- Oncology (2195)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (481)
- Public and Global Health (6754)
- Radiology and Imaging (1484)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)